Abstract:The incidence and mortality rate of cancer has been quickly increasing in the past decades. At present, cancer has become the leading cause of death worldwide. Most of the cancers cannot be effectively diagnosed at the early stage. Although there are multiple therapeutic treatments, including surgery, radiotherapy, chemotherapy, and targeted drugs, their effectiveness is still limited. The overall survival rate of malignant cancers is still low. It is necessary to further study the mechanisms for malignant cancers, and explore new biomarkers and targets that are more sensitive and effective for early diagnosis, treatment, and prognosis of cancers than traditional biomarkers and methods. Long non-coding RNAs (lncRNAs) are a class of RNA transcripts with a length greater than 200 nucleotides. Generally, lncRNAs are not capable of encoding proteins or peptides. LncRNAs exert diverse biological functions by regulating gene expressions and functions at transcriptional, translational, and post-translational levels. In the past decade, it has been demonstrated that the dysregulated lncRNA profile is widely involved in the pathogenesis of many diseases, including cancer, metabolic disorders, and cardiovascular diseases. In particular, lncRNAs have been revealed to play an important role in tumor growth and metastasis. Many lncRNAs have been shown to be potential biomarkers and targets for the diagnosis and treatment of cancers. This review aims to briefly discuss the latest findings regarding the roles and mechanisms of some important lncRNAs in the pathogenesis of certain malignant cancers, including lung, breast, liver, and colorectal cancers, as well as hematological malignancies and neuroblastoma.

Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs As Novel Biomarkers and Potential Therapeutic Targets for Cancer

Dysregulation Of Long Non-Coding Rna In Breast Cancer: An Overview Of Mechanism And Clinical Implication

Long Noncoding RNA: Its Partners and Their Roles in Cancer

Role of Cytoplasmic Lncrnas in Regulating Cancer Signaling Pathways

Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets

The Role of Long Noncoding RNAs in Cancer: the Dark Matter Matters.

Comprehensive Genomic Characterization of Long Non-coding RNAs Across Human Cancers.

Targetable long non-coding RNAs in cancer treatments.

Exosomal Long Non-Coding RNAs: Biological Properties and Therapeutic Potential in Cancer Treatment

Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects

Long Non-Coding Rnas in Non-Small Cell Lung Cancer As Biomarkers and Therapeutic Targets

Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy

Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.

Long Noncoding RNAs: Fine-Tuners Hidden in the Cancer Signaling Network

Long Non-Coding RNA and Non-Coding Nucleic Acids: Signaling Players in the Networks of the Tumor Ecosystem

Integrative Analysis Reveals Clinical Phenotypes and Oncogenic Potentials of Long Non-Coding RNAs Across 15 Cancer Types.

The Emerging Role and Promise of Long Noncoding RNAs in Lung Cancer Treatment

Long Non-Coding RNA in the Pathogenesis of Cancers

Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer.

Long Non-Coding RNAs: an Emerging Powerhouse in the Battle Between Life and Death of Tumor Cells

Targeting long non-coding RNAs in cancers: progress and prospects